Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting NCT07690228 Sponsor: Acta Pharmaceuticals Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting

NCT07690228
Not Yet Recruiting Phase 1 🇦🇺 Australian site

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are healthy and between 18 and 55 years old.
  • People who score between 27 and 30 on a standard memory and thinking test (called the MMSE) at the screening visit.
  • People who are able to give their own written agreement to take part.
  • People who are in good general health with no conditions expected to interfere with the study.
  • People who can read, speak, and understand English well enough to complete thinking and memory tests during the study.
  • People who are able to walk independently and willing to stay at the clinic for the required study procedures.
  • Women who could become pregnant must agree to use a highly effective form of birth control (as confirmed by the study doctor) from enrolment through the entire study, and must have a negative pregnancy test at screening — accepted methods include hormonal contraception (pill, patch, or vaginal ring), progestogen-only methods (pill, injection, or implant), an intrauterine device (IUD), an intrauterine hormone-releasing system, having both fallopian tubes blocked or removed, complete abstinence from heterosexual sex, or having a sole sexual partner who has had a vasectomy confirmed as successful by a doctor.
  • Women who cannot become pregnant are defined as those who have had a hysterectomy, both ovaries removed, both fallopian tubes removed, or who have gone through menopause.
  • Men whose partners could become pregnant must be willing to either abstain from sex or use double-barrier contraception during the study and for one week after the last dose of the study treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a history of any significant condition affecting the stomach or gut, kidneys, liver, lungs, nervous system, mental health, heart, hormones, eyes, blood, or a significant allergy or metabolic disorder.
  • People who are currently taking any medications, other than birth control methods that have been stable for at least 30 days before the study begins.
  • People with a history of regularly using anti-inflammatory pain medicines (such as ibuprofen or naproxen), or who have had a procedure using dye injected into a vein within 72 hours of the study starting.
  • People with a history of a psychiatric condition such as schizophrenia, bipolar disorder, or major depression, as defined by the current standard diagnostic guidelines.
  • People who currently have any thoughts of suicide, or who have previously attempted suicide, as assessed by a standard rating scale used in the study.
  • People who have been diagnosed with a brain-degenerating condition or dementia, including Alzheimer's disease, Parkinson's disease, or Huntington's disease.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 13017580468

Australian sites

Nucleus Network Pty Ltd, Melbourne, Victoria
1800 243 733

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Acta Pharmaceuticals
Registry
ClinicalTrials.gov
Start date
15 August 2026
Est. completion
15 August 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Safety Evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov